Source: Schering Foundation • 1992 , (Center for Molecular Biology,
University of Heidelberg, Germany) • 1993
Christiane Nüsslein-Volhard, (
Max Planck Institute for Developmental Biology in Tübingen, Germany) • 1994
Bert Vogelstein, (Oncology Center,
Johns Hopkins University, Baltimore, Maryland, US) • 1995
Yasutomi Nishizuka, (
Kobe University, Japan) • 1996
Judah Folkman, (
Harvard Medical School,
Harvard University, Boston, US) • 1997
Johann Mulzer, (Institute for Organic Chemistry,
University of Vienna, Austria) • 1998
Ilme Schlichting, (
Max Planck Institute for Molecular Physiology in Dortmund, Germany) • 1999
Michael Berridge, (
Babraham Institute in Cambridge, UK) • 2000 , (
University of Tokyo, Japan) • 2001
Kyriacos Nicolaou, (
University of California, San Diego, California, and
The Scripps Research Institute, La Jolla, California, US) • 2002
Ian Wilmut, (
The Roslin Institute in Edinburgh, UK) • 2003
Svante Pääbo, (
Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany) • 2004 , (
National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, US) • 2005
Thomas Tuschl, (Laboratory of RNA Molecular Biology,
Rockefeller University, New York) • 2006
Wolfgang Baumeister, (
Max Planck Institute of Biochemistry in Martinsried, Germany) • 2007
Carolyn Bertozzi, (
University of California, Berkeley, US) • 2008
Klaus Rajewsky, (
Harvard Medical School, Boston, US) • 2009
Rudolf Jaenisch, (
Whitehead Institute, Cambridge, Massachusetts, US) • 2010
Marc Feldmann and Sir
Ravinder Maini, (Kennedy Institute of Rheumatology at Imperial College London, UK) • 2011
Bert W. O'Malley, (Tom Thompson Distinguished Service Professor and Chair of Molecular and Cellular Biology at
Baylor College of Medicine in Houston, Texas) • 2012
Matthias Mann, (
Max Planck Institute of Biochemistry in Martinsried, Germany) • 2013 , (Institute of Molecular Virology at the
Ulm University Medical Center in Ulm, Germany) • 2014
Magdalena Götz, (Director of the Institute of Stem Cell Research at the Helmholtz Zentrum München and chair of Physiological Genomics at
LMU Munich in Germany) • 2015
David MacMillan, (Professor of Chemistry at
Princeton University, US). • 2016
Franz-Ulrich Hartl, (
Max Planck Institute of Biochemistry in Martinsried, Germany). • 2017
Elly Tanaka, (Senior Scientist at
Research Institute of Molecular Pathology in Vienna, Austria) • 2018
Bonnie L. Bassler, (Princeton University, New Jersey) • 2019
Patrick Cramer, (Director at the
Max Planck Institute for Biophysical Chemistry in Göttingen) • 2020 , (Director at the in Cologne) • 2021
Aviv Regev, (Head of
Genentech Research and Early Development in South San Francisco, US) • 2022 (Professor of Computer-Assisted Drug Design at the Institute of Pharmaceutical Sciences at ETH Zurich and director of the Singapore-ETH Center) • 2023
Matthias Tschöp (CEO and scientific director at
Helmholtz Zentrum München, Germany. Alexander von Humboldt Professor at the
Technical University of Munich (TUM), and Helmholtz Vice President of Health Research) • 2024
Maiken Nedergaard (Dean's Professor and Co-Director of the Center for Translational Neuromedicine at the
University of Rochester Medical Center in Rochester, NY, and Professor of Glial Cell Biology at the Center for Neuroscience at the
University of Copenhagen in Denmark) • 2025
Volker Haucke (director at the
Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and professor at
Freie Universität Berlin ==See also==